Xvivo Perfusion AB (publ) (STO: XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	16,789	10,379	5,459	8,215	9,018	4,522
Market Cap Growth	44.23%	90.12%	-33.55%	-8.90%	99.42%	29.75%
Enterprise Value	16,336	9,810	5,150	7,936	8,417	4,331
Last Close Price	533.00	329.50	183.00	278.50	314.00	170.00
PE Ratio	135.79	107.42	295.16	994.64	-195.08	944.45
PS Ratio	23.46	17.37	13.15	31.79	50.14	20.48
PB Ratio	8.29	5.34	3.82	6.39	8.94	7.83
P/FCF Ratio	2903.70	3172.09	564.50	-369.18	-605.34	237.98
P/OCF Ratio	188.87	224.23	195.98	-681.27	-735.19	153.27
EV/Sales Ratio	23.38	16.42	12.40	30.71	46.80	19.61
EV/EBITDA Ratio	216.34	515.41	387.15	-678.25	-229.94	368.87
EV/EBIT Ratio	294.53	1818.08	1156.31	-423.41	-190.49	1090.62
EV/FCF Ratio	2825.26	2998.27	532.54	-356.61	-565.02	227.92
Debt / Equity Ratio	0.01	0.02	0.01	0.00	0.01	0.01
Debt / EBITDA Ratio	0.36	1.06	0.51	-	-	0.37
Debt / FCF Ratio	4.70	9.61	1.03	-0.26	-0.48	0.29
Asset Turnover	0.34	0.30	0.25	0.19	0.20	0.36
Inventory Turnover	1.22	1.23	1.29	1.02	0.97	1.45
Quick Ratio	3.27	4.94	2.60	4.43	5.51	3.97
Current Ratio	4.13	6.14	3.47	5.24	6.41	4.94
Return on Equity (ROE)	6.84%	5.44%	1.36%	0.71%	-5.52%	0.88%
Return on Assets (ROA)	1.32%	0.17%	0.17%	-0.87%	-3.09%	0.41%
Return on Capital (ROIC)	1.49%	0.20%	0.20%	-1.02%	-3.45%	0.44%
Earnings Yield	0.74%	0.88%	0.34%	0.10%	-0.48%	0.11%
FCF Yield	0.03%	0.03%	0.18%	-0.27%	-0.17%	0.42%
Buyback Yield / Dilution	-3.61%	-1.39%	-2.04%	-6.49%	-1.39%	-1.89%
Total Shareholder Return	-3.61%	-1.39%	-2.04%	-6.49%	-1.39%	-1.89%

Source: S&P Capital IQ. Standard template. Financial Sources.